Report Detail
Global Investigational New Drug Contract Development and Manufacturing Market Insights, Forecast to 2028
- RnM4378309 |
- 31 January, 2022 |
- Global |
- 107 Pages |
- QYResearch |
- Medical Industry
Summary:
Market Analysis and Insights: Global Investigational New Drug Contract Development and Manufacturing Market
The global Investigational New Drug Contract Development and Manufacturing market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.
Fully considering the economic change by this health crisis, Contract Development accounting for % of the Investigational New Drug Contract Development and Manufacturing global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Pharmaceutical segment is altered to an % CAGR throughout this forecast period.
China Investigational New Drug Contract Development and Manufacturing market size is valued at US$ million in 2021, while the North America and Europe Investigational New Drug Contract Development and Manufacturing are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Investigational New Drug Contract Development and Manufacturing landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Investigational New Drug Contract Development and Manufacturing market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Investigational New Drug Contract Development and Manufacturing market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Investigational New Drug Contract Development and Manufacturing market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Investigational New Drug Contract Development and Manufacturing market.
Impact of Covid-19 Outbreak
This section of the report has explored the overall status of the Covid scenario and has offered valuable insights into the changes in supply chain disruption, fluctuations in demand, etc. The analysts have also focused on the key measures that the companies are opting to withstand the harsh scenario.
Segmental Analysis
The report has been segmented into product and application segments. The researchers have documented all the products present today in the Investigational New Drug Contract Development and Manufacturing market. They have also shed light on the new product innovations and launches by the key players. In the segmental analysis, the analysts have provided revenue forecast figures based on type and application for the period 2017-2028. They have also discussed about the growth rate and potential of each segment for the period 2017-2028.
Investigational New Drug Contract Development and Manufacturing Breakdown Data by Type
Contract Development
Contract Manufacturing
Investigational New Drug Contract Development and Manufacturing Breakdown Data by Application
Pharmaceutical
Biotechnology
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Competitive Landscape
This segment focuses on the key players operating in the industry. It underlines all the current and future activities by the prominent manufacturers. By understanding various initiatives being taken up by different players, readers will gain the ability to settle on correct business choices. The authors of the report have provided accurate revenue figures of the companies for the period 2017-2022. The clients are sure to gain the upper hand once they get hold of this report. Key players studied in the research report include:
Covance Inc.
Charles River Laboratories Inc.
Cambrex Corporation
IQVIA Holdings Inc.
Syneos Health
Lonza
Catalent
Recipharm AB
Siegfried Holding AG
Thermo Fisher Scientific Inc.
Frequently Asked Questions
What factors will challenge the Investigational New Drug Contract Development and Manufacturing market growth?
Which end-use segment will expand at the fastest CAGR in the Investigational New Drug Contract Development and Manufacturing market?
Which are the emerging players in the Investigational New Drug Contract Development and Manufacturing market?
How concentrated is the Investigational New Drug Contract Development and Manufacturing market?
Which factors are positively contributing to the Investigational New Drug Contract Development and Manufacturing market growth?
Which are the novel product innovations in the Investigational New Drug Contract Development and Manufacturing market?
Which product segment will emerge as the most lucrative in the Investigational New Drug Contract Development and Manufacturing market?
Which factors are increasing the competition in the Investigational New Drug Contract Development and Manufacturing market?
Which are the strategic measures taken by the Investigational New Drug Contract Development and Manufacturing industry players?
Which region will witness inactive growth during the forecast period?
What key trends are likely to emerge in the Investigational New Drug Contract Development and Manufacturing market in the coming years?
Table of Contents
1 Report Business Overview
- 1.1 Study Scope
- 1.2 Market Analysis by Type
- 1.2.1 Global Investigational New Drug Contract Development and Manufacturing Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
- 1.2.2 Contract Development
- 1.2.3 Contract Manufacturing
- 1.3 Market by Application
- 1.3.1 Global Investigational New Drug Contract Development and Manufacturing Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
- 1.3.2 Pharmaceutical
- 1.3.3 Biotechnology
- 1.3.4 Others
- 1.4 Study Objectives
- 1.5 Years Considered
2 Global Growth Trends
- 2.1 Global Investigational New Drug Contract Development and Manufacturing Market Perspective (2017-2028)
- 2.2 Investigational New Drug Contract Development and Manufacturing Growth Trends by Region
- 2.2.1 Investigational New Drug Contract Development and Manufacturing Market Size by Region: 2017 VS 2021 VS 2028
- 2.2.2 Investigational New Drug Contract Development and Manufacturing Historic Market Size by Region (2017-2022)
- 2.2.3 Investigational New Drug Contract Development and Manufacturing Forecasted Market Size by Region (2023-2028)
- 2.3 Investigational New Drug Contract Development and Manufacturing Market Dynamics
- 2.3.1 Investigational New Drug Contract Development and Manufacturing Industry Trends
- 2.3.2 Investigational New Drug Contract Development and Manufacturing Market Drivers
- 2.3.3 Investigational New Drug Contract Development and Manufacturing Market Challenges
- 2.3.4 Investigational New Drug Contract Development and Manufacturing Market Restraints
3 Competition Landscape by Key Players
- 3.1 Global Top Investigational New Drug Contract Development and Manufacturing Players by Revenue
- 3.1.1 Global Top Investigational New Drug Contract Development and Manufacturing Players by Revenue (2017-2022)
- 3.1.2 Global Investigational New Drug Contract Development and Manufacturing Revenue Market Share by Players (2017-2022)
- 3.2 Global Investigational New Drug Contract Development and Manufacturing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
- 3.3 Players Covered: Ranking by Investigational New Drug Contract Development and Manufacturing Revenue
- 3.4 Global Investigational New Drug Contract Development and Manufacturing Market Concentration Ratio
- 3.4.1 Global Investigational New Drug Contract Development and Manufacturing Market Concentration Ratio (CR5 and HHI)
- 3.4.2 Global Top 10 and Top 5 Companies by Investigational New Drug Contract Development and Manufacturing Revenue in 2021
- 3.5 Investigational New Drug Contract Development and Manufacturing Key Players Head office and Area Served
- 3.6 Key Players Investigational New Drug Contract Development and Manufacturing Product Solution and Service
- 3.7 Date of Enter into Investigational New Drug Contract Development and Manufacturing Market
- 3.8 Mergers & Acquisitions, Expansion Plans
4 Investigational New Drug Contract Development and Manufacturing Breakdown Data by Type
- 4.1 Global Investigational New Drug Contract Development and Manufacturing Historic Market Size by Type (2017-2022)
- 4.2 Global Investigational New Drug Contract Development and Manufacturing Forecasted Market Size by Type (2023-2028)
5 Investigational New Drug Contract Development and Manufacturing Breakdown Data by Application
- 5.1 Global Investigational New Drug Contract Development and Manufacturing Historic Market Size by Application (2017-2022)
- 5.2 Global Investigational New Drug Contract Development and Manufacturing Forecasted Market Size by Application (2023-2028)
6 North America
- 6.1 North America Investigational New Drug Contract Development and Manufacturing Market Size (2017-2028)
- 6.2 North America Investigational New Drug Contract Development and Manufacturing Market Size by Type
- 6.2.1 North America Investigational New Drug Contract Development and Manufacturing Market Size by Type (2017-2022)
- 6.2.2 North America Investigational New Drug Contract Development and Manufacturing Market Size by Type (2023-2028)
- 6.2.3 North America Investigational New Drug Contract Development and Manufacturing Market Share by Type (2017-2028)
- 6.3 North America Investigational New Drug Contract Development and Manufacturing Market Size by Application
- 6.3.1 North America Investigational New Drug Contract Development and Manufacturing Market Size by Application (2017-2022)
- 6.3.2 North America Investigational New Drug Contract Development and Manufacturing Market Size by Application (2023-2028)
- 6.3.3 North America Investigational New Drug Contract Development and Manufacturing Market Share by Application (2017-2028)
- 6.4 North America Investigational New Drug Contract Development and Manufacturing Market Size by Country
- 6.4.1 North America Investigational New Drug Contract Development and Manufacturing Market Size by Country (2017-2022)
- 6.4.2 North America Investigational New Drug Contract Development and Manufacturing Market Size by Country (2023-2028)
- 6.4.3 United States
- 6.4.4 Canada
7 Europe
- 7.1 Europe Investigational New Drug Contract Development and Manufacturing Market Size (2017-2028)
- 7.2 Europe Investigational New Drug Contract Development and Manufacturing Market Size by Type
- 7.2.1 Europe Investigational New Drug Contract Development and Manufacturing Market Size by Type (2017-2022)
- 7.2.2 Europe Investigational New Drug Contract Development and Manufacturing Market Size by Type (2023-2028)
- 7.2.3 Europe Investigational New Drug Contract Development and Manufacturing Market Share by Type (2017-2028)
- 7.3 Europe Investigational New Drug Contract Development and Manufacturing Market Size by Application
- 7.3.1 Europe Investigational New Drug Contract Development and Manufacturing Market Size by Application (2017-2022)
- 7.3.2 Europe Investigational New Drug Contract Development and Manufacturing Market Size by Application (2023-2028)
- 7.3.3 Europe Investigational New Drug Contract Development and Manufacturing Market Share by Application (2017-2028)
- 7.4 Europe Investigational New Drug Contract Development and Manufacturing Market Size by Country
- 7.4.1 Europe Investigational New Drug Contract Development and Manufacturing Market Size by Country (2017-2022)
- 7.4.2 Europe Investigational New Drug Contract Development and Manufacturing Market Size by Country (2023-2028)
- 7.4.3 Germany
- 7.4.4 France
- 7.4.5 U.K.
- 7.4.6 Italy
- 7.4.7 Russia
- 7.4.8 Nordic Countries
8 Asia-Pacific
- 8.1 Asia-Pacific Investigational New Drug Contract Development and Manufacturing Market Size (2017-2028)
- 8.2 Asia-Pacific Investigational New Drug Contract Development and Manufacturing Market Size by Type
- 8.2.1 Asia-Pacific Investigational New Drug Contract Development and Manufacturing Market Size by Type (2017-2022)
- 8.2.2 Asia-Pacific Investigational New Drug Contract Development and Manufacturing Market Size by Type (2023-2028)
- 8.2.3 Asia-Pacific Investigational New Drug Contract Development and Manufacturing Market Share by Type (2017-2028)
- 8.3 Asia-Pacific Investigational New Drug Contract Development and Manufacturing Market Size by Application
- 8.3.1 Asia-Pacific Investigational New Drug Contract Development and Manufacturing Market Size by Application (2017-2022)
- 8.3.2 Asia-Pacific Investigational New Drug Contract Development and Manufacturing Market Size by Application (2023-2028)
- 8.3.3 Asia-Pacific Investigational New Drug Contract Development and Manufacturing Market Share by Application (2017-2028)
- 8.4 Asia-Pacific Investigational New Drug Contract Development and Manufacturing Market Size by Region
- 8.4.1 Asia-Pacific Investigational New Drug Contract Development and Manufacturing Market Size by Region (2017-2022)
- 8.4.2 Asia-Pacific Investigational New Drug Contract Development and Manufacturing Market Size by Region (2023-2028)
- 8.4.3 China
- 8.4.4 Japan
- 8.4.5 South Korea
- 8.4.6 Southeast Asia
- 8.4.7 India
- 8.4.8 Australia
9 Latin America
- 9.1 Latin America Investigational New Drug Contract Development and Manufacturing Market Size (2017-2028)
- 9.2 Latin America Investigational New Drug Contract Development and Manufacturing Market Size by Type
- 9.2.1 Latin America Investigational New Drug Contract Development and Manufacturing Market Size by Type (2017-2022)
- 9.2.2 Latin America Investigational New Drug Contract Development and Manufacturing Market Size by Type (2023-2028)
- 9.2.3 Latin America Investigational New Drug Contract Development and Manufacturing Market Share by Type (2017-2028)
- 9.3 Latin America Investigational New Drug Contract Development and Manufacturing Market Size by Application
- 9.3.1 Latin America Investigational New Drug Contract Development and Manufacturing Market Size by Application (2017-2022)
- 9.3.2 Latin America Investigational New Drug Contract Development and Manufacturing Market Size by Application (2023-2028)
- 9.3.3 Latin America Investigational New Drug Contract Development and Manufacturing Market Share by Application (2017-2028)
- 9.4 Latin America Investigational New Drug Contract Development and Manufacturing Market Size by Country
- 9.4.1 Latin America Investigational New Drug Contract Development and Manufacturing Market Size by Country (2017-2022)
- 9.4.2 Latin America Investigational New Drug Contract Development and Manufacturing Market Size by Country (2023-2028)
- 9.4.3 Mexico
- 9.4.4 Brazil
10 Middle East & Africa
- 10.1 Middle East & Africa Investigational New Drug Contract Development and Manufacturing Market Size (2017-2028)
- 10.2 Middle East & Africa Investigational New Drug Contract Development and Manufacturing Market Size by Type
- 10.2.1 Middle East & Africa Investigational New Drug Contract Development and Manufacturing Market Size by Type (2017-2022)
- 10.2.2 Middle East & Africa Investigational New Drug Contract Development and Manufacturing Market Size by Type (2023-2028)
- 10.2.3 Middle East & Africa Investigational New Drug Contract Development and Manufacturing Market Share by Type (2017-2028)
- 10.3 Middle East & Africa Investigational New Drug Contract Development and Manufacturing Market Size by Application
- 10.3.1 Middle East & Africa Investigational New Drug Contract Development and Manufacturing Market Size by Application (2017-2022)
- 10.3.2 Middle East & Africa Investigational New Drug Contract Development and Manufacturing Market Size by Application (2023-2028)
- 10.3.3 Middle East & Africa Investigational New Drug Contract Development and Manufacturing Market Share by Application (2017-2028)
- 10.4 Middle East & Africa Investigational New Drug Contract Development and Manufacturing Market Size by Country
- 10.4.1 Middle East & Africa Investigational New Drug Contract Development and Manufacturing Market Size by Country (2017-2022)
- 10.4.2 Middle East & Africa Investigational New Drug Contract Development and Manufacturing Market Size by Country (2023-2028)
- 10.4.3 Turkey
- 10.4.4 Saudi Arabia
- 10.4.5 UAE
11 Key Players Profiles
- 11.1 Covance Inc.
- 11.1.1 Covance Inc. Company Details
- 11.1.2 Covance Inc. Business Overview
- 11.1.3 Covance Inc. Investigational New Drug Contract Development and Manufacturing Introduction
- 11.1.4 Covance Inc. Revenue in Investigational New Drug Contract Development and Manufacturing Business (2017-2022)
- 11.1.5 Covance Inc. Recent Developments
- 11.2 Charles River Laboratories Inc.
- 11.2.1 Charles River Laboratories Inc. Company Details
- 11.2.2 Charles River Laboratories Inc. Business Overview
- 11.2.3 Charles River Laboratories Inc. Investigational New Drug Contract Development and Manufacturing Introduction
- 11.2.4 Charles River Laboratories Inc. Revenue in Investigational New Drug Contract Development and Manufacturing Business (2017-2022)
- 11.2.5 Charles River Laboratories Inc. Recent Developments
- 11.3 Cambrex Corporation
- 11.3.1 Cambrex Corporation Company Details
- 11.3.2 Cambrex Corporation Business Overview
- 11.3.3 Cambrex Corporation Investigational New Drug Contract Development and Manufacturing Introduction
- 11.3.4 Cambrex Corporation Revenue in Investigational New Drug Contract Development and Manufacturing Business (2017-2022)
- 11.3.5 Cambrex Corporation Recent Developments
- 11.4 IQVIA Holdings Inc.
- 11.4.1 IQVIA Holdings Inc. Company Details
- 11.4.2 IQVIA Holdings Inc. Business Overview
- 11.4.3 IQVIA Holdings Inc. Investigational New Drug Contract Development and Manufacturing Introduction
- 11.4.4 IQVIA Holdings Inc. Revenue in Investigational New Drug Contract Development and Manufacturing Business (2017-2022)
- 11.4.5 IQVIA Holdings Inc. Recent Developments
- 11.5 Syneos Health
- 11.5.1 Syneos Health Company Details
- 11.5.2 Syneos Health Business Overview
- 11.5.3 Syneos Health Investigational New Drug Contract Development and Manufacturing Introduction
- 11.5.4 Syneos Health Revenue in Investigational New Drug Contract Development and Manufacturing Business (2017-2022)
- 11.5.5 Syneos Health Recent Developments
- 11.6 Lonza
- 11.6.1 Lonza Company Details
- 11.6.2 Lonza Business Overview
- 11.6.3 Lonza Investigational New Drug Contract Development and Manufacturing Introduction
- 11.6.4 Lonza Revenue in Investigational New Drug Contract Development and Manufacturing Business (2017-2022)
- 11.6.5 Lonza Recent Developments
- 11.7 Catalent
- 11.7.1 Catalent Company Details
- 11.7.2 Catalent Business Overview
- 11.7.3 Catalent Investigational New Drug Contract Development and Manufacturing Introduction
- 11.7.4 Catalent Revenue in Investigational New Drug Contract Development and Manufacturing Business (2017-2022)
- 11.7.5 Catalent Recent Developments
- 11.8 Recipharm AB
- 11.8.1 Recipharm AB Company Details
- 11.8.2 Recipharm AB Business Overview
- 11.8.3 Recipharm AB Investigational New Drug Contract Development and Manufacturing Introduction
- 11.8.4 Recipharm AB Revenue in Investigational New Drug Contract Development and Manufacturing Business (2017-2022)
- 11.8.5 Recipharm AB Recent Developments
- 11.9 Siegfried Holding AG
- 11.9.1 Siegfried Holding AG Company Details
- 11.9.2 Siegfried Holding AG Business Overview
- 11.9.3 Siegfried Holding AG Investigational New Drug Contract Development and Manufacturing Introduction
- 11.9.4 Siegfried Holding AG Revenue in Investigational New Drug Contract Development and Manufacturing Business (2017-2022)
- 11.9.5 Siegfried Holding AG Recent Developments
- 11.10 Thermo Fisher Scientific Inc.
- 11.10.1 Thermo Fisher Scientific Inc. Company Details
- 11.10.2 Thermo Fisher Scientific Inc. Business Overview
- 11.10.3 Thermo Fisher Scientific Inc. Investigational New Drug Contract Development and Manufacturing Introduction
- 11.10.4 Thermo Fisher Scientific Inc. Revenue in Investigational New Drug Contract Development and Manufacturing Business (2017-2022)
- 11.10.5 Thermo Fisher Scientific Inc. Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
- 13.1 Research Methodology
- 13.1.1 Methodology/Research Approach
- 13.1.2 Data Source
- 13.2 Author Details
Summary:
Get latest Market Research Reports on Investigational New Drug Contract Development and Manufacturing . Industry analysis & Market Report on Investigational New Drug Contract Development and Manufacturing is a syndicated market report, published as Global Investigational New Drug Contract Development and Manufacturing Market Insights, Forecast to 2028. It is complete Research Study and Industry Analysis of Investigational New Drug Contract Development and Manufacturing market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
